A change in business environment causes a significant transformation in their operations. In the pharmaceutical industry, technological change leads to a massive transformation in drugs production. A business model canvas is an essential management plan that helps to analyze the current values condition using a template or structural presentation (Dudin et al, 2018, p.34). AstraZeneca is a biopharmaceutical firm, which was established in 1992. The company introduces, develop, and commercialization prescribed drugs which treat and prevent various diseases.
Business model Canvas
Key Partners
Key Activities
Value Proportional
Customers
Relationship
Customers
Segments
Subsidiaries
Numerous corporate acquisition (Cambridge Antibody Technology, MedImmune, Spirogen and Definiens)
Regulatory agencies
FDA
Independent research Centers
Medical Community
Research partnerships
The scientific community of investigators
Research and development
Clinical trials
Manufacturing
Quality control
Networking
Intellectual property protection
Marketing
To push the boundaries of science to deliver life-changing medicines
Providing access to healthcare for all those who need it is a significant and complex global challenge
A portfolio of products for major disease areas (cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation)
Patients first
Reputation
Brand awareness
Tradition
Recommendation (from medical community)
Collaboration
Co-creation
Research and development know-how
Expertise and experience
People with specific medical conditions
Physician
Healthcare institutions
Key Resources
Channels
50,000 employees
Scientist
Intellectual property
Facilities
Research and development headquarter
High quality staff of researchers
Open innovation
Research and Development Challenges
Data packages
High throughput screening libraries and facilities
Cheminiformaties and other silico analyses
Salesforce
Distribution networks and pharmacies
Medical community
AstraZeneca website
Social media such as Facebook and Twitter
Publication
Cost Structure
Revenue Streams
Research and development
Staff compensation
Research facilities
Raw material
Manufacturing cost
Technology and facilities
Maintenance
Sale of products
Licensing
Royalties on intellectual property
Company Analysis
In an organization, value proportion is a critical factor that influences production and distribution of products. In AstraZeneca Company, contemporary information such as customers’ behaviors influences its value proportional. This information helps the company to understand the factors that attract and maintain loyalty customers (Blasi, Caruso, and Viganò, 2017, p.214). Customers’ preference, for example, over-the-counter drugs affect the value proportional and client segments. The company produces products which are based on customers’ need. Therefore, production of drugs which prevent and treat various diseases such as respiratory issues help the company to maintain its customers. The values in the company are arranged based on how products serve customers’ needs (Urban et al., 2018, p.34).
AstraZeneca Company operates in the manufacturing business model. The company produce raw materials and sells to either retailers or wholesalers. Research and development department is mandated to introduce new drugs products based on customers need and environmental change. In most cases, this form of business model is based on long-term investment (Joyce and Paquin, 2016, p.1478).
The organization values are drafted based on their strategies. The company has an effective leadership system, which translates strategy into actions. This action creates a sustainable value proportional at all level. Additionally, the action helps the company to create a competitive advantage through value transformation. The principle of technology transformation is another factor that influence value proportional (Muhtaroglu et al., 2013, p.36). In AstraZeneca, technology is a critical factor that is used in various departments such as the research and development. Technology system helps the company to extract and analyze product to introduce new drugs. Environmental change is accompanied by the introduction of new diseases which required for both preventive and curative drugs (Osterwalder and Pigneur, 2018, p.34).
Bibliography
Blasi, G., Caruso, A. and Viganò, E., 2017. Participatory design of a sustainable school canteen through the development of a Business Model Canvas. Economia agro-alimentare/Food Economy, 18(3).
Dudin, M., Kucuri, G., Fedorova, I., Dzusova, S. and Namitulina, A., 2015. The innovative business model canvas in the system of effective budgeting. New York, NY: Routledge.
Joyce, A. and Paquin, R.L., 2016. The triple-layered business model canvas: A tool to design more sustainable business models. Journal of Cleaner Production, 135, pp.1474-1486.
Muhtaroglu, F.C.P., Demir, S., Obali, M. and Girgin, C., 2013, October. Business model canvas perspective on big data applications. In Big Data, 2013 IEEE International Conference on (pp. 32-37). IEEE.
Osterwalder, A. and Pigneur, Y., 2010. Business model generation: a handbook for visionaries, game changers, and challengers. Los Angeles, LA: John Wiley " Sons.
Urban, M., Klemm, M., Ploetner, K.O. and Hornung, M., 2018. Airline categorisation by applying the business model canvas and clustering algorithms. Journal of Air Transport Management.
